Spots Global Cancer Trial Database for Hippocampal-sparing Whole Brain Radiotherapy for Brain Metastases From Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Hippocampal-sparing Whole Brain Radiotherapy for Brain Metastases From Breast Cancer
Official Title: Whole Brain Irradiation With Hippocampal Sparing for Brain Metastases From Breast Cancer: Neurocognitive Function and Prognosis Analysis
Study ID: NCT03002532
Interventions
Study Description
Brief Summary: Based on evidence that radiation-induced damage to the hippocampus plays a considerable role in neurocognitive decline after cranial irradiation, hippocampal-sparing whole brain radiation therapy (HS-WBRT) has been proposed. This study will investigate the neurocognitive function and prognosis between HS-WBRT and conventional WBRT for the treatment of brain metastases from breast cancer.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Affiliated Hospital of Academy of Military Medical Sciences, Beijing, Beijing, China
Contact Details
Name: Bing Sun, M.D.
Affiliation: Affiliated Hospital of Academy of Military Medical Sciences
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
